Titan Pharmaceuticals News - TTNP

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Titan Pharmaceuticals Inc TTNP NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.1159 46.36% 0.3659 0.383 0.28 0.28 0.25 14:50:57
more quote information »

Recent News

Date Time Source Heading
1/16/202017:21EDGARCurrent Report Filing (8-k)
1/13/202015:15EDGARAmended Statement of Ownership (sc 13g/a)
1/13/202008:00PRNUSTitan Pharmaceuticals Announces Addition Of Probuphine® To..
1/09/202016:24EDGARSmall Company Offering and Sale of Securities Without..
1/07/202017:32EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
1/07/202017:19EDGARCurrent Report Filing (8-k)
1/07/202016:27EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
1/07/202009:15PRNUSTitan Pharmaceuticals Announces Pricing of $2.2 Million..
12/31/201906:04EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
12/30/201908:00PRNUSTitan Pharmaceuticals Appoints Dr. Kate DeVarney To Its..
12/23/201913:38EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
12/20/201917:14EDGARCurrent Report Filing (8-k)
12/10/201914:31EDGARCurrent Report Filing (8-k)
12/03/201909:00PRNUSTitan Pharmaceuticals To Present At The First Annual..
11/20/201906:03EDGARProxy Statement (definitive) (def 14a)
11/14/201916:11EDGARQuarterly Report (10-q)
11/14/201916:03PRNUSTitan Pharmaceuticals Reports Third Quarter 2019 Financial..
11/07/201916:30PRNUSTitan Pharmaceuticals To Release Third Quarter 2019..
11/04/201906:03EDGARProxy Statement - Notice of Shareholders Meeting..
10/22/201909:56EDGARStatement of Ownership (sc 13g)
10/22/201908:00PRNUSTitan Pharmaceuticals To Present Two Posters On Probuphine®..
10/18/201916:33EDGARCurrent Report Filing (8-k)
10/17/201913:19EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
10/17/201906:01EDGARNotice of Effectiveness (effect)
10/16/201909:20PRNUSTitan Pharmaceuticals Announces Pricing Of $9.0 Million..
10/11/201913:44EDGARSecurities Registration Statement (s-1/a)
10/08/201917:29EDGARSecurities Registration Statement (s-1/a)
10/01/201908:00PRNUSTitan Pharmaceuticals and Crossroads of Southern Nevada..
9/30/201906:02EDGARSecurities Registration Statement (s-1/a)
9/20/201911:30EDGARCurrent Report Filing (8-k)
9/20/201909:46EDGARConfidential Treatment Order (ct Order)
9/18/201917:30EDGARCurrent Report Filing (8-k)
9/18/201908:00PRNUSTitan Receives Approval For Second Year Of NIDA Grant..
9/12/201909:29EDGARSecurities Registration Statement (s-1)
8/23/201911:36EDGARCurrent Report Filing (8-k)
8/19/201917:27EDGARSmall Company Offering and Sale of Securities Without..
8/14/201916:13EDGARQuarterly Report (10-q)
8/14/201916:03PRNUSTitan Pharmaceuticals Reports Second Quarter 2019 Financial..
8/09/201917:00PRNUSTitan Pharmaceuticals To Release Second Quarter 2019..
8/07/201912:46EDGARStatement of Ownership (sc 13g)
8/07/201909:15PRNUSTitan Pharmaceuticals Announces Pricing Of $2.1 Million..
7/09/201909:00PRNUSTitan Pharmaceuticals Expands Patient Access To Probuphine®..
6/27/201916:12EDGARCurrent Report Filing (8-k)
6/26/201909:10PRNUSTitan Pharmaceuticals And Molteni Receive European..
6/07/201916:21EDGARStatement of Changes in Beneficial Ownership (4)
6/04/201907:00PRNUSTitan Pharmaceuticals Partners With Southside To Further..
5/15/201916:16EDGARQuarterly Report (10-q)
5/15/201916:03PRNUSTitan Pharmaceuticals Reports First Quarter 2019 Financial..
5/13/201907:00PRNUSTitan Pharmaceuticals Further Expands Patient Access To..
5/08/201920:00PRNUSTitan Pharmaceuticals To Release First Quarter 2019..
See more news about this stock »
Your Recent History
NASDAQ
TTNP
Titan Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200117 20:05:57